Interleukin 17 role as a biomarker in Systemic Lupus Erythematosus patients.

Interleukin 26 in patients with systemic lupus erythematosus

Serum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Circulating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity

Interleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity

Serum interleukins 2 and 10 in juvenile systemic lupus erythematosus: relation to disease activity

Association between interleukin -4 gene polymorphism with the risk and disease activity of Egyptian patients with systemic lupus erythematosus

Role of Interleukin-18, S-adenosylmethionine and SAdenosylhomocysteine as Cardiovascular Risk Factors in Patients with Systemic Lupus Erythematosus

Study of Interleukin-17 and Fc Gamma Receptor in SLE Patients and Its Relation to Disease Activity and Clinical Presentation